Biontech broadens management board by appointing jens holstein as cfo

Mainz, germany, may 18, 2021 —  biontech se (nasdaq: bntx, “biontech” or “the company”), announced today that the supervisory board has appointed jens holstein to the management board as chief financial officer (cfo). as of july 1, 2021, jens holstein will join the management board to help strengthen biontech on its growth trajectory as a global, fully integrated immunotherapy company with an approved or authorized product. he previously served as cfo for morphosys ag and in various cfo and general management roles within the fresenius se group. jens holstein takes over the cfo role from dr. sierk poetting who will fully focus on his tasks as chief operating officer (coo) going forward.
BNTX Ratings Summary
BNTX Quant Ranking